SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-08-046599
Filing Date
2008-08-07
Accepted
2008-08-06 17:40:09
Documents
3
Period of Report
2008-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 DR. MOREADITH APPOINTMENT rrd215153.htm 8-K 16024
2 PRESS RELEASE ENTITLED, "NEKTAR THERAPEUTICS NAMES RANDALL MOREADITH, M.D., PH.D rrd215153_25404.htm EX-99.1 6082
3 OFFER LETTER AGREEMENT BETWEEN NEKTAR THERAPEUTICS AND DR. MOREADITH DATED JULY rrd215153_25407.htm EX-10.1 10214
  Complete submission text file 0001181431-08-046599.txt   34036
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 08995970
SIC: 2834 Pharmaceutical Preparations